These findings suggest potential therapeutic implications for targeted therapy as they confirm SPINK1’s role as an acute-phase reactant and its involvement in paracrine crosstalk within the colon cancer tumor microenvironment [16]. This evidence concerns the gene SPINK1 and malignant colon neoplasm.